Pfizer RSV Vaccine May Protect High-Risk Adults Ages 18-59

Respiratory syncytial virus: viral vaccine under investigation Hail | Stock | fake images a vaccine Pfizer showed the potential to…

Biotech stocks are ready to break out. They just need one more thing

As debate continues over when the Federal Reserve might begin cutting interest rates, biotech industry analysts argue that the case…